WallStreetZenWallStreetZen

NASDAQ: DMII
Drugs Made In America Acquisition II Corp Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Drugs Made In America Acquisition II earnings were $13.0M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest DMII earnings report on Jun 30, 2026 announced Q2 2026 earnings of $4.4M, up 1.4% from last quarter.

DMII earnings history

Current Revenue
$0.0
Current Earnings
$13.0M
Current Profit Margin
0%

DMII Return on Equity

Current Company
-73.6%
Current Industry
231.1%
Current Market
32.8%
DMII's Return on Equity (-73.6%)... subscribe to Premium to read more.
High Return on Equity Performance

DMII Return on Assets

Current Company
2.6%
Current Industry
-1.9%
DMII is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DMII announces earnings.

DMII Return on Capital Employed

Current Company
2.54%
Current Industry
-1.6%

DMII vs Shell Company Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DMII$13.02M$13.02MN/A$0.31
BCSS$12.28M$12.28MN/A$0.32
EVAC$16.85M$16.85MN/A$0.31
CXIIN/AN/AN/AN/A
CEPF$14.23M$14.23MN/A$0.33
View Top Shell Company Stocks

Drugs Made In America Acquisition II Earnings Reports & History FAQ

What were Drugs Made In America Acquisition II's earnings last quarter?

Drugs Made In America Acquisition II (NASDAQ: DMII) reported Q2 2026 earnings per share (EPS) of $0.07, up Infinity% year over year. Total DMII earnings for the quarter were $4.40 million. In the same quarter last year, Drugs Made In America Acquisition II's earnings per share (EPS) was $0.00.

If you're new to stock investing, here's how to buy Drugs Made In America Acquisition II stock.

Is Drugs Made In America Acquisition II profitable or losing money?

As of the last Drugs Made In America Acquisition II earnings report, Drugs Made In America Acquisition II is currently profitable. Drugs Made In America Acquisition II's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $13.02 million, a N/A decrease year over year.

What was DMII's earnings growth in the past year?

As of Drugs Made In America Acquisition II's earnings date in Q3 2026, Drugs Made In America Acquisition II's earnings has grown year over year. DMII earnings in the past year totalled $13.02 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.